Invesco Nasdaq Biotechnology ETF Rating $22.04 -0.34 (-1.50%) Closing price 07/11/2025 03:53 PM EasternExtended Trading$22.04 0.00 (0.00%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.70Holdings in IBBQ have an aggregate rating of Moderate Buy based on 771 analyst ratings issued in the past year covering 50 companies (80.3% of the portfolio).IBBQ Aggregate Price Target$22.04High Prediction$22.04Average Prediction$22.04Low Prediction$22.04Holdings in IBBQ have an aggregate price target of $22.04 and a range of $22.04 to $22.04 covering 50 companies (80.3% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.83%VRTXVertex Pharmaceuticals$468.85-2.2%4.3239 of 5 stars2.54$511.62 9.1%28Positive NewsAnalyst Revision7.77%GILDGilead Sciences$109.64-4.3%4.9348 of 5 stars2.77$111.38 1.6%26Positive NewsAnalyst Revision7.72%AMGNAmgen$295.27-1.7%4.4353 of 5 stars2.35$307.82 4.2%23Positive NewsAnalyst Revision6.23%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8321 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst ForecastAnalyst Revision4.67%AZNAstraZeneca$71.13-0.9%3.7571 of 5 stars2.83$89.00 25.1%6Positive NewsAnalyst Forecast4.04%ALNYAlnylam Pharmaceuticals$314.94-2.4%4.1804 of 5 stars2.80$345.70 9.8%25Positive NewsAnalyst Forecast2.10%BIIBBiogen$134.21-0.8%4.7768 of 5 stars2.38$188.48 40.4%32Trending NewsAnalyst Revision1.96%INSMInsmed$98.18+1.6%4.3684 of 5 stars3.00$108.07 10.1%17Positive NewsAnalyst ForecastInsider Trade1.89%ARGXargenex$560.24-0.5%4.4131 of 5 stars3.10$728.06 30.0%21Analyst Upgrade1.74%SMMTSummit Therapeutics$25.00-3.4%2.8485 of 5 stars2.79$34.67 38.7%141.72%ILMNIllumina$99.25-0.8%4.8696 of 5 stars2.40$125.11 26.1%20Trending NewsAnalyst Forecast1.67%RPRXRoyalty Pharma$35.84-0.8%4.9768 of 5 stars3.25$48.33 34.9%4Positive NewsAnalyst Forecast1.52%SNYSanofi$48.61-1.5%4.1428 of 5 stars3.11$61.50 26.5%9Trending NewsAnalyst Revision1.47%INCYIncyte$68.59-2.5%4.7311 of 5 stars2.22$74.53 8.7%181.45%UTHRUnited Therapeutics$295.52-1.5%4.9888 of 5 stars2.69$383.08 29.6%13News CoveragePositive NewsAnalyst Forecast1.40%NBIXNeurocrine Biosciences$133.46-1.1%4.5451 of 5 stars2.87$163.91 22.8%23Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.32%EXELExelixis$44.86-0.7%4.785 of 5 stars2.48$44.72 -0.3%21Positive NewsAnalyst Forecast1.23%MRNAModerna$33.64-1.9%4.306 of 5 stars2.04$46.61 38.6%23Trending News1.19%VTRSViatris$9.12-1.4%2.9044 of 5 stars1.80$10.40 14.0%51.19%BNTXBioNTech$112.89-0.9%1.6374 of 5 stars2.83$137.91 22.2%18News CoverageAnalyst Forecast1.19%BMRNBioMarin Pharmaceutical$58.10-1.2%4.9453 of 5 stars2.75$93.61 61.1%24News CoveragePositive News1.15%ASNDAscendis Pharma A/S$174.96-0.9%3.6014 of 5 stars3.00$223.07 27.5%15News CoverageAnalyst Forecast1.12%ONCBeOne Medicines$250.30-1.2%3.4372 of 5 stars3.00$320.67 28.1%6Trending NewsAnalyst DowngradeInsider Trade1.11%TEMTempus AI$56.88-4.6%2.2898 of 5 stars2.50$65.09 14.4%12Trending NewsInsider Trade1.02%MEDPMedpace$323.50-1.4%4.2753 of 5 stars2.21$344.82 6.6%14News CoverageAnalyst Revision0.92%BPMCBlueprint Medicines$129.300.0%1.2225 of 5 stars2.24$128.25 -0.8%21Positive NewsInsider TradeHigh Trading Volume0.90%BBIOBridgeBio Pharma$46.47+0.4%4.6022 of 5 stars3.00$60.21 29.6%14Analyst Upgrade0.82%ROIVRoivant Sciences$11.36-1.8%2.8285 of 5 stars3.25$16.50 45.2%4News CoveragePositive NewsAnalyst Upgrade0.79%VRNAVerona Pharma PLC American Depositary Share$104.830.0%2.3793 of 5 stars2.31$107.45 2.5%13Trending NewsAnalyst ForecastHigh Trading Volume0.76%RVMDRevolution Medicines$38.02-1.2%4.574 of 5 stars3.00$68.00 78.9%110.75%JAZZJazz Pharmaceuticals$110.27-2.0%4.8352 of 5 stars2.92$184.00 66.9%13Trending News0.74%MDGLMadrigal Pharmaceuticals$315.46+0.3%4.2573 of 5 stars2.89$420.63 33.3%9Positive News0.72%HALOHalozyme Therapeutics$57.15-0.8%4.8225 of 5 stars2.17$62.50 9.4%12News CoverageAnalyst ForecastInsider Trade0.70%IONSIonis Pharmaceuticals$41.73-1.5%4.6661 of 5 stars2.78$58.25 39.6%18Positive News0.69%GHGuardant Health$50.25-2.0%4.116 of 5 stars3.00$53.76 7.0%210.57%NUVLNuvalent$80.93-1.4%3.3693 of 5 stars3.17$119.60 47.8%12Insider Trade0.56%AXSMAxsome Therapeutics$108.98-1.6%4.7671 of 5 stars3.06$172.33 58.1%16Analyst Revision0.53%ALKSAlkermes$30.28-0.6%4.7999 of 5 stars2.83$40.00 32.1%12Positive News0.47%ADMAADMA Biologics$18.51+0.2%3.9527 of 5 stars3.33$27.67 49.5%3Positive News0.47%PCVXVaxcyte$35.93-0.9%1.8263 of 5 stars3.10$136.50 279.9%10News CoveragePositive News0.46%RYTMRhythm Pharmaceuticals$86.70-2.6%3.1905 of 5 stars3.07$91.00 5.0%15Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.46%CRSPCRISPR Therapeutics$56.80-3.7%3.2427 of 5 stars2.53$71.75 26.3%17Analyst ForecastOptions Volume0.45%AKROAkero Therapeutics$51.57-0.8%3.3965 of 5 stars3.00$82.50 60.0%6Insider Trade0.44%CYTKCytokinetics$37.01+1.1%4.0737 of 5 stars2.93$70.92 91.6%150.44%KRYSKrystal Biotech$148.17-1.0%4.6697 of 5 stars3.00$213.75 44.3%9Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.43%PTCTPTC Therapeutics$48.55-2.0%4.5686 of 5 stars2.67$65.00 33.9%15Positive News0.40%MRUSMerus$54.50-1.1%1.9242 of 5 stars3.14$84.64 55.3%14News CoverageAnalyst UpgradeInsider Trade0.40%ACADACADIA Pharmaceuticals$20.98-4.9%4.6508 of 5 stars2.71$27.88 32.9%17Positive NewsAnalyst Revision0.39%ACLXArcellx$68.98+0.2%2.5588 of 5 stars3.07$111.23 61.3%15Positive News0.38%RNAAvidity Biosciences$31.45-0.1%2.187 of 5 stars3.06$66.35 111.0%17News CoverageAnalyst UpgradeHigh Trading Volume This page (NASDAQ:IBBQ) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
